A meta-analysis suggests allogeneic stem cell transplantation (allo-SCT) should not be recommended following first-line ...

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

While citing overwhelming barriers patients in rural areas face when accessing care, providers noted the potential of telehealth to improve access in a survey.

TP53 aberrations and circulating tumor DNA burden were found to be predictors of poor outcomes in high-risk patients with ...

The findings provide insight into which patients may have favorable or inferior responses to immunotherapy for small cell ...

Defining "value" in cancer care goes beyond survival and should encompass patient quality of life metrics, said Coral Omene, MD, PhD, of Robert Wood Johnson Medical School. Value in cancer care can go ...

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.